We refer to the SAHPRA communication dated 8 January 2026 concerning the regulatory review of certain paediatric supplement formulations containing zinc picolinate and selenium, particularly in syrup dosage forms .  The purpose of this correspondence is to provide clarity regarding our product range and to outline the steps we are taking to ensure continued alignment with regulatory guidance. Read the official statement from Release SCE CEO, Anél Coetzee.

Exams can be stressful, but with the right preparation and mental support, you can set yourself up for success. At Release SCE, we...

Why they say: “You’re a fool when you’re in love.” What love is and the science behind it.